These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3540271)

  • 21. Thromboxane and prostacyclin in acute lung injury caused by venous air emboli in unanesthetized sheep.
    Bonsignore MR; Rice TR; Dodek PM; Staub NC
    Microcirc Endothelium Lymphatics; 1986; 3(2):187-212. PubMed ID: 3295507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of thromboxane synthase inhibition on tumor necrosis factor-induced lung injury in sheep.
    Koizumi T; Kubo K; Kobayashi T; Sekiguchi M
    J Appl Physiol (1985); 1992 Aug; 73(2):618-24. PubMed ID: 1399989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of celecoxib on pulmonary hypertension of chronic hypoxia and hypercapnic rats].
    Zeng HH; Liu LJ; Huang YP; Xie YP; Wang LX
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Feb; 27(1):29-32. PubMed ID: 21560334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hypoxic pulmonary vasoconstriction by carbon monoxide in dogs.
    Vassalli F; Pierre S; Julien V; Bouckaert Y; Brimioulle S; Naeije R
    Crit Care Med; 2001 Feb; 29(2):359-66. PubMed ID: 11246317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model.
    Wiklund A; Kylhammar D; Rådegran G
    J Cardiovasc Pharmacol; 2012 May; 59(5):441-9. PubMed ID: 22240915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG; Barnes PJ; Evans TW
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of endogenous nitric oxide synthesis enhances acute hypoxic pulmonary vasoconstriction].
    Cao WB; Zhu YJ; Luo WC
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Jun; 17(3):148-51, 189. PubMed ID: 7834769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid.
    Tod ML; Cassin S
    J Appl Physiol (1985); 1985 Mar; 58(3):710-6. PubMed ID: 3920192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular changes in group B streptococcal sepsis in the piglet: response to indomethacin and relationship to prostacyclin and thromboxane A2.
    Runkle B; Goldberg RN; Streitfeld MM; Clark MR; Buron E; Setzer ES; Bancalari E
    Pediatr Res; 1984 Sep; 18(9):874-8. PubMed ID: 6384909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of selective alpha 1-adrenoceptor blockade in dogs with hypoxic pulmonary vasoconstriction.
    Yoshioka T; Obayashi Y; Nakanishi N; Naito M; Okubo S; Kunieda T
    Jpn Circ J; 1988 Oct; 52(10):1201-8. PubMed ID: 2905392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of thromboxane A2 on chronic hypoxic pulmonary hypertension in the rat].
    Saito M; Tatsumi K; Kasahara Y; Sugito K; Igari H; Tani T; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):37-44. PubMed ID: 8717289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thromboxane synthase inhibition on air emboli lung injury in sheep.
    Fukushima M; Kobayashi T
    J Appl Physiol (1985); 1986 Jun; 60(6):1828-33. PubMed ID: 3755131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostacyclin and thromboxane A2 moderate postischemic renal failure.
    Lelcuk S; Alexander F; Kobzik L; Valeri CR; Shepro D; Hechtman HB
    Surgery; 1985 Aug; 98(2):207-12. PubMed ID: 3895535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
    Young TE; Lundquist LJ; Chesler E; Weir EK
    Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of arachidonate metabolites to abnormal control of the pulmonary circulation in a child.
    Barst RJ; Stalcup SA; Steeg CN; Hall JC; Frosolono MF; Cato AE; Mellins RB
    Am Rev Respir Dis; 1985 Jan; 131(1):171-7. PubMed ID: 3917630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute effects of captopril in hypoxic pulmonary hypertension. Comparison with transient oxygen administration.
    Boschetti E; Tantucci C; Cocchieri M; Fornari G; Grassi V; Sorbini CA
    Respiration; 1985; 48(4):296-302. PubMed ID: 3909277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog.
    Archer SL; Chesler E; Cohn JN; Weir EK
    J Am Coll Cardiol; 1986 Nov; 8(5):1189-94. PubMed ID: 2428854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course and responses of sustained hypoxic pulmonary vasoconstriction in the dog.
    Domino KB; Chen L; Alexander CM; Williams JJ; Marshall C; Marshall BE
    Anesthesiology; 1984 Jun; 60(6):562-6. PubMed ID: 6731911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.